Brain Resource Names Louis Gagnon as new CEO

Brain Resource

Australia-listed Brain Resource Limited (ASX:BRC) has announced the appointment of Louis Gagnon as Chief Executive Officer. Evian Gordon will continue to serve as chairman of the company.

Gagnon comes to BRC with 25 years of experience as a successful, high-growth, global digital business leader. He said the company has created unique scientific assets that can be scaled and built upon to significantly expand the company’s share of the global corporate wellness market evaluated at USD9.4 billion in 2017.

In a disclosure to the Australian Securities Exchange, BRC said Gagnon intends to leverage the company’s Holistic Brain Assessment / Training tools and its standardised Neuroscientific Database (the world’s largest), to empower individuals from around the world to Assess, Compare and Optimize the core brain processes that power their health and wellbeing.

“I have spent my career focused on creating social change while generating successful
shareholder outcomes. Brain Resource is the largest shareholder value creation opportunity that I have been associated with and it also is the largest social change opportunity. I am very humbled and grateful for the work that has led us here and I cannot be more excited to build the team and execute the strategy that will take this great work to the next level,” Gagnon said.

READ ALSO: AHAlife Names Sebastian Kaufmann as New CEO

Brain Resource Chairman Dr. Evian Gordon added said Gagnon is an extremely well-credentialed leader of high-growth technology companies with a significant personal interest in brain performance.

“He has extensive relationships across the technology and investment community and provides shareholders with a proven track record in establishing market adoption and repeat purchase of innovative products in high frequency. Louis has the vision
and capability to lead BRC into its promising future,” Gordon said.

Brain Resource Ltd is an international medical research company. It maintains the results of clinical trials which in some cases include sensitive private information. Brain resource operates in the US and Europe as well as Australia. –